Unique ID issued by UMIN | UMIN000058307 |
---|---|
Receipt number | R000066572 |
Scientific Title | A Prospective Comparative Study of ACT Measurement Variability Between Different Cartridges in Cardiac Surgery with Cardiopulmonary Bypass |
Date of disclosure of the study information | 2025/08/01 |
Last modified on | 2025/06/27 23:35:57 |
A Study Comparing ACT Measurement Differences Between Cartridges in Cardiac Surgery with Cardiopulmonary Bypass
ACT Cartridge Comparison in Cardiac Surgery
A Prospective Comparative Study of ACT Measurement Variability Between Different Cartridges in Cardiac Surgery with Cardiopulmonary Bypass
ACT Measurement Comparison with Cardiopulmonary Bypass
Japan |
Cardiac diseases requiring cardiovascular surgery with cardiopulmonary bypass (regurgitant valvular disease, stenotic valvular disease, aortic aneurysm, ischemic heart disease)
Anesthesiology | Cardiovascular surgery |
Others
NO
This study aims to investigate the impact of differences between two types of ACT measurement cartridges (JACT-LR and JACT+) used with the Hemochron Signature Elite on ACT values during cardiac surgery with cardiopulmonary bypass.
Safety,Efficacy
ACT values and the differences between measurement cartridges (JACT-LR and JACT+) at the following time points: induction of anesthesia, after protamine reversal following weaning from cardiopulmonary bypass, and at the end of surgery
Correlation between ACT values obtained from each measurement device and APTT
Observational
18 | years-old | <= |
Not applicable |
Male and Female
Age: 18 years or older
Surgical procedure: Cardiovascular surgery using cardiopulmonary bypass (including valve replacement, valve repair, aortic replacement, and coronary artery bypass grafting)
Diseases: Cardiac diseases for which the above surgical procedures are indicated (such as regurgitant valvular disease, stenotic valvular disease, aortic aneurysm, and ischemic heart disease)
Timing of surgery to be included: From the date of approval by the institution's director to March 31, 2026
Consent: Patients who have provided written informed consent themselves or through a legally authorized representative
Patients with antiphospholipid syndrome
Patients currently participating in a clinical trial or specified clinical research
50
1st name | Takayuki |
Middle name | |
Last name | Morimoto |
Nagasaki University Hospital
Department of Anesthesiology
852-8102
1-7-1 Sakamoto, Nagasaki, JAPAN
095-819-7370
tmorimoto@nagasaki-u.ac.jp
1st name | Takayuki |
Middle name | |
Last name | Morimoto |
Nagasaki University Hospital
Department of Anesthesiology
852-8102
1-7-1 Sakamoto, Nagasaki, JAPAN
095-819-7370
tmorimoto@nagasaki-u.ac.jp
Nagasaki University Hospital
Department of Anesthesiology, Nagasaki University Hospital
Other
Nagasaki University Hospital Clinical Research Ethics Committee
1-7-1 Sakamoto, Nagasaki, JAPAN
095-819-7229
gaibushikin@ml.nagasaki-u.ac.jp
NO
2025 | Year | 08 | Month | 01 | Day |
Unpublished
Preinitiation
2025 | Year | 07 | Month | 01 | Day |
2025 | Year | 08 | Month | 01 | Day |
2026 | Year | 03 | Month | 31 | Day |
Single-center forward-looking observational study
This study will include 50 patients who undergo cardiovascular surgery using artificial cardiopulmonary bypass in the operating room of Nagasaki University Hospital from the date of approval by the head of the research institute.
2025 | Year | 06 | Month | 27 | Day |
2025 | Year | 06 | Month | 27 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000066572